Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

Registration for FDA’s Rare Disease Day 2024 (from Catapult’s regulatory round-up – December 2023)

The Virtual Public Meeting will be held on 1 March 2024 from 9AM – 4:30PM EST. This year’s Rare Disease Day is dedicated to patients and health care professionals. Panels will discuss:

  • The legal framework for approving studies and medical products at FDA
  • What FDA does during review processes to approve medical products
  • Decentralized clinical trials and digital health technologies
  • Where to find important information and documents related to clinical trials
  • Information that can be obtained from medical product labels
  • Legal and ethical requirements for consent forms in clinical trials
  • FDA initiatives to advance medical product development for rare diseases
  • Ways for patients to engage with FDA

Please find information on how to register here.

Published on the 5th of January 2024. Read the entire regulatory round-up for December 2023 here.


OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (7 août 2024). Registration for FDA’s Rare Disease Day 2024 (from Catapult’s regulatory round-up – December 2023). ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/1258q


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.